Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation

•BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end.•Concurrent hysterectomy at time of RRBSO may be considered to ensu...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Gynecologic oncology reports Ročník 37; s. 100795
Hlavní autoři: Badiner, Nora, Nchako, Corbyn M., Ma, Lucy, Frey, Melissa K.
Médium: Journal Article
Jazyk:angličtina
Vydáno: Elsevier Inc 01.08.2021
Elsevier
Témata:
ISSN:2352-5789, 2352-5789
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:•BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end.•Concurrent hysterectomy at time of RRBSO may be considered to ensure all tubal epithelium is resected. Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
Bibliografie:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ISSN:2352-5789
2352-5789
DOI:10.1016/j.gore.2021.100795